Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2013

Jul 31, 2013

30150_dirs_2013-07-31_c318b58f-20c3-4141-a0db-b2eb4bd67b71.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED INC (INSM)
CIK: 0001104506
Period of Report: 2013-07-30

Reporting Person: Pellizzari Christine A (General Counsel & Secretary)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-07-30 Stock Option-Right to Buy $11.14 A 150000 Acquired 2023-07-30 Common Stock (150000) Direct

Footnotes

F1: These options become exercisable with respect to 25% of the shares of common stock subject to this grant on July 29, 2014, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each six month anniversary of July 29, 2014 thereafter through July 29, 2017.